Treating HCT15‐CT45A1 cells with ML‐7 also decreased MLC2 phosphorylation (Fig. S7E) and sensitized cancer cells to NK cell killing (Fig. S7F), suggesting that MLCK activation also occurs in CT45A1‐expressing CRC cells. The gene discussed is CT45A1; the disease is cancer.